Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 18;45(1):412.
doi: 10.1007/s10792-025-03781-2.

Patient-reported visual difficulties associated with geographic atrophy from age-related macular degeneration

Affiliations

Patient-reported visual difficulties associated with geographic atrophy from age-related macular degeneration

Liangbo Linus Shen et al. Int Ophthalmol. .

Abstract

Purpose: To characterize visual difficulties associated with geographic atrophy (GA).

Methods: A prospective study included 91 participants with bilateral GA. A visual activities questionnaire was administered at baseline and annually for 2 years along with best-corrected visual acuity (BCVA) and GA size. Baseline questionnaire responses were compared using logistic regressions, and longitudinal changes were analyzed with generalized linear mixed-effect models. A small group of 12 participants with drusen without GA served as a comparison to participants with GA and good VA.

Results: Compared to drusen participants, bilateral GA participants with BCVA of 20/50 or better reported significantly more difficulties in 8 vision-specific tasks. The frequencies of difficulty in reading small print, trouble with face recognition, and stopping driving were positively associated with GA severity cross-sectionally, measured by either BCVA or GA size, and increased over 2 years (P < 0.05 for each). Additional significant longitudinal changes included difficulty seeing in dim light (P = 0.005) and locating a sign (P = 0.008).

Conclusion: Reading, vision in dim illumination, face recognition, locating signs, and driving worsen over 2 years in patients with GA, and may be the appropriate self-reported items to monitor in a clinical trial. These findings highlight the need for therapies addressing both GA enlargement and visual function decline.

Keywords: Age-related macular degeneration; Best-corrected visual acuity; Geographic atrophy; Quality of life; Visual activities questionnaire; Visual function.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: Authors CAA and GSR declare that they have no financial interests. LLS has received consultant honoraria from Boehringer Ingelheim and Sanofi. JSS serves as the chair of DSMB for OpRegen trial. Ethical approval: This is an observational study. The Wilmer Eye Institute Institutional Review Board has approved the study. Consent to participate: Informed consent was obtained from all individual participants included in the study.

References

    1. Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:e106–e116 - DOI - PubMed
    1. Goldstein JE, Massof RW, Deremeik JT, Braudway S, Jackson ML, Kehler KB, Primo SA, Sunness JS, Low Vision Research Network Study Group ft (2012) Baseline traits of low vision patients served by private outpatient clinical centers in the United States. Arch Ophthalmol 130:1028–1037. https://doi.org/10.1001/archophthalmol.2012.1197 - DOI - PubMed - PMC
    1. Klein R, Klein BEK, Tomany SC, Meuer SM, Huang G-H (2002) Ten-year incidence and progression of age-related maculopathy: the Beaver Dam eye study1 1the authors have no proprietary interest in the products or devices mentioned herein. Ophthalmology 109:1767–1779. https://doi.org/10.1016/S0161-6420(02)01146-6 - DOI - PubMed
    1. Hirvelä H, Luukinen H, Läärä E, Sc L, Laatikainen L (1996) Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 103:871–877. https://doi.org/10.1016/s0161-6420(96)30593-9 - DOI - PubMed
    1. Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ (2023) Efficacy and safety of avacincaptad pegol in patients with Geographic Atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet 402:1449–1458. https://doi.org/10.1016/s0140-6736(23)01583-0 - DOI - PubMed

MeSH terms

LinkOut - more resources